Effective Friday, September 17, a province-wide mandatory masking order will be implemented for all indoor public spaces. 

Google Translate Disclaimer

A number of pages on the Government of Saskatchewan's website have been professionally translated in French. These translations are identified by a yellow box in the right or left rail that resembles the link below. The home page for French-language content on this site can be found at:

Renseignements en Français

Where an official translation is not available, Google™ Translate can be used. Google™ Translate is a free online language translation service that can translate text and web pages into different languages. Translations are made available to increase access to Government of Saskatchewan content for populations whose first language is not English.

Software-based translations do not approach the fluency of a native speaker or possess the skill of a professional translator. The translation should not be considered exact, and may include incorrect or offensive language. The Government of Saskatchewan does not warrant the accuracy, reliability or timeliness of any information translated by this system. Some files or items cannot be translated, including graphs, photos and other file formats such as portable document formats (PDFs).

Any person or entities that rely on information obtained from the system does so at his or her own risk. Government of Saskatchewan is not responsible for any damage or issues that may possibly result from using translated website content. If you have any questions about Google™ Translate, please visit: Google™ Translate FAQs.

Saskatchewan Supporting Patients with Hepatitis with New Drug

Released on July 28, 2015

Saskatchewan is marking World Hepatitis Day, July 28, joining efforts to raise awareness of the disease and support people living with hepatitis. 

“Our government continues to support residents in accessing health services and new, effective treatment options,” Health Minister Dustin Duncan said.  “Beginning August 1, the province will begin providing coverage for Holkira Pak, a new lifesaving drug for patients with hepatitis C who meet certain medical criteria.” 

Holkira Pak is the third new hepatitis C drug to be listed on the Saskatchewan Formulary in addition to Harvoni and Sovaldi, listed earlier this year.  These new drug therapies offer effective, simple and fast treatment for chronic hepatitis C, and can cure patients in as little as eight to twelve weeks.  Over the next three years, Saskatchewan expects to provide coverage for about 1,100 patients who will meet the Exception Drug Status criteria for these drugs. 

“In addition to providing drug therapies, our province continues efforts to enhance prevention, encourage testing, and provide patient centred-services,” Duncan said.  “We’re committed to working closely with our partners and I want to thank them all for their involvement and support.” 

Hepatitis is a viral disease that causes inflammation of the liver.  The most common types of viral hepatitis are hepatitis A, B and C. Hepatitis B or C can cause serious, long-term complications such as severe, permanent liver damage, liver failure and liver cancer. 

For more information on hepatitis including symptoms, diagnosis and treatment, call HealthLine at 811 or visit www.healthlineonline.ca

For more information on the drug approval process and income assisted programs, contact Drug Plan and Extended Benefits Branch at 1-800-667-7581 or 306-787-3317 in Regina.


For more information, contact:

Tyler McMurchy
Phone: 306-787-4083
Email: tmcmurchy@health.gov.sk.ca

We need your feedback to improve saskatchewan.ca. Help us improve